Used in pharmaceutical research as a key intermediate for synthesizing biologically active compounds, particularly in the development of drugs targeting neurological and psychiatric disorders. Its structure, featuring a Boc-protected amine and a fluorophenyl group, makes it valuable for creating peptide-based therapeutics and enzyme inhibitors. The fluorine atom enhances binding affinity and metabolic stability, making it useful in designing molecules with improved pharmacokinetic properties. Commonly employed in medicinal chemistry for optimizing drug candidates during preclinical studies.